Parker Institute for Cancer Immunotherapy
Parker Institute for Cancer Immunotherapy
Main page

Parker Institute for Cancer Immunotherapy

logo
Community Hub0 subscribers
What are your thoughts?
Be the first to start a discussion here.
Be the first to start a discussion here.
Parker Institute for Cancer Immunotherapy

The Parker Institute for Cancer Immunotherapy (PICI) is an American program focused on the acceleration of cancer immunotherapy located in San Francisco. The institute includes over 40 laboratories from several key cancer centers, Weill Cornell, Stanford Medicine, Gladstone Institute, UCLA, University of Pennsylvania, and the Dana-Farber Cancer Institute.

The institute was established in 2016 through the Parker Foundation by a $250 million grant from Sean Parker. The institute was originally focused around three key areas of research, modification of T-cells, boosting the patient response to immunotherapy drugs, and research on novel targets. Jeffrey Bluestone was the inaugural president of the institute.

PICI uses an organizational model to tie funding and science together. The PICI Network includes a number of cancer research centers. The PICI network involves:

See all
User Avatar
No comments yet.